Teva to buy Ratiopharm for nearly $5 billion (Reuters)

[Mgtrben news]

Reuters - Israel's Teva has won the battle for German generic drugmaker Ratiopharm, paying an enterprise value of 3.625 billion euros to fix the industry leader's weakness in the world's second-largest generics market.

Source (http://us.rd.**********/dailynews/rss/tech/*http://news.**********/s/nm/20100318/bs_nm/us_ratiopharm)